Onda Takeshi, Goto Osamu, Otsuka Toshiaki, Hayasaka Yoshiaki, Nakagome Shun, Habu Tsugumi, Ishikawa Yumiko, Kirita Kumiko, Koizumi Eriko, Noda Hiroto, Higuchi Kazutoshi, Omori Jun, Akimoto Naohiko, Iwakiri Katsuhiko
Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Bunkyo-ku 113-8603, Tokyo, Japan.
Endoscopy Center, Nippon Medical School Hospital, Bunkyo-ku 113-8603, Tokyo, Japan.
World J Gastrointest Endosc. 2024 Mar 16;16(3):136-147. doi: 10.4253/wjge.v16.i3.136.
Tumor size impacts the technical difficulty and histological curability of colorectal endoscopic submucosal dissection (ESD); however, the preoperative evaluation of tumor size is often different from histological assessment. Analyzing influential factors on failure to obtain an accurate tumor size evaluation could help prepare optimal conditions for safer and more reliable ESD.
To investigate the tumor size discrepancy between endoscopic and pathological evaluations and the influencing factors.
This was a retrospective study conducted at a single institution. A total of 377 lesions removed by colorectal ESD at our hospital between April 2018 and March 2022 were collected. We first assessed the difference in size with an absolute percentage of the scaling discrepancy. Subsequently, we compared the clinicopathological characteristics of the correct scaling group (> -33% and < 33%) with that of the incorrect scaling group (< -33% or > 33%), which was further subdivided into the underscaling group (-33% or less of the discrepancy) and overscaling group (33% or more of the discrepancy), respectively. As secondary outcome measures, parameters on size estimation were compared between the underscaling and correct scaling groups, as well as between the overscaling and correct scaling groups. Finally, multivariate analysis was performed in terms of the following relevant parameters on size estimation: Pathological size, location, and possible influential factors ( < 0.1) in the univariate analysis.
The mean of absolute percentage in the scaling discordance was 21%, and 91 lesions were considered to be incorrectly estimated in size. The incorrect scaling was significantly remarkable in larger lesions (40 mm 28 mm; < 0.001) and less experience ( < 0.001), and these two factors were influential on the underscaling (75 lesions; < 0.001). Conversely, compared with the correct scaling group, 16 lesions in the overscaling group were significantly small (20 mm 28 mm; < 0.001), and the small lesion size was influential on the overscaling ( = 0.002).
Lesions indicated for colorectal ESD tended to be underestimated in large tumors, but overestimated in small ones. This discrepancy appears worth understanding for optimal procedural preparation.
肿瘤大小会影响结直肠内镜黏膜下剥离术(ESD)的技术难度和组织学可治愈性;然而,肿瘤大小的术前评估往往与组织学评估不同。分析影响无法准确评估肿瘤大小的因素有助于为更安全、更可靠的ESD准备最佳条件。
探讨内镜评估与病理评估之间的肿瘤大小差异及影响因素。
这是一项在单一机构进行的回顾性研究。收集了2018年4月至2022年3月间在我院通过结直肠ESD切除的377个病变。我们首先用缩放差异的绝对百分比评估大小差异。随后,我们比较了正确缩放组(>-33%且<33%)与错误缩放组(<-33%或>33%)的临床病理特征,错误缩放组又分别细分为缩放不足组(差异的-33%或更小)和缩放过度组(差异的33%或更大)。作为次要结局指标,比较了缩放不足组与正确缩放组之间以及缩放过度组与正确缩放组之间大小估计的参数。最后,根据以下大小估计的相关参数进行多变量分析:病理大小、位置以及单变量分析中可能有影响的因素(<0.1)。
缩放不一致的绝对百分比平均值为21%,91个病变被认为大小估计错误。在较大病变(40毫米对28毫米;<0.001)和经验较少(<0.001)的情况下,错误缩放明显更显著,这两个因素对缩放不足有影响(75个病变;<0.001)。相反,与正确缩放组相比,缩放过度组中的16个病变明显较小(20毫米对28毫米;<0.001),小病变大小对缩放过度有影响(P=0.002)。
结直肠ESD所针对的病变在大肿瘤中往往被低估,但在小肿瘤中往往被高估。这种差异对于优化手术准备似乎值得了解。